Hans Biomed Corp Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Hans Biomed Corp

Watchlist Manager

Watchlist

Price: 17 780 KRW 2.66% Market Closed

Market Cap: ₩253.5B

H	Hans Biomed Corp KOSDAQ:042520	KR
	NVIDIA Corp MIL:1NVDA	US
P	Pitney Bowes Inc DUS:PBW	US

Profitability Summary

Hans Biomed Corp's profitability score is 17/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

60%

Strong 3Y Average Gross Margin

61%

Gross Margin is Increasing

58% > 60%

Negative Operating Margin

-13%

Negative 3Y Average Operating Margin

-4%

Declining Operating Margin

-2% > -13%

Negative Net Margin

-16%

Negative 3Y Average Net Margin

-18%

Declining Net Margin

-9% > -16%

Negative Free Cash Flow Margin

-15%

Negative 3Y Average Free Cash Flow Margin

-8%

Declining Free Cash Flow Margin

-11% > -15%

Negative ROE

-28%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-4%

Declining ROIC

-1% > -15%

View All

Hide

Collapse

17 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.